Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer
Overall, FPLC chemoradiotherapy influences SPLC prognosis and influences sensitivity to treatment. Tailoring SPLC management to FPLC treatment regimens may improve survival outcomes.
Authors
- Jiangjiang Liu
- Gaoming Wang
- Zhe Chen (ORCID: https://orcid.org/0000-0002-8654-9218)
- Nan Wang (ORCID: https://orcid.org/0000-0002-3413-1450)
- Yao Yu (ORCID: https://orcid.org/0000-0003-0774-3897)
- Jing Luo (ORCID: https://orcid.org/0000-0002-8057-4068)
- Kai Xie
- Haitao Ma (ORCID: https://orcid.org/0000-0003-3655-039X)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Xuzhou Medical College (CN)
- Nanjing General Hospital of Nanjing Military Command (CN)
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Xuzhou Central Hospital (CN)
- Nanjing Second Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.3389/fimmu.2025.1492501
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00